» Articles » PMID: 22171199

The Effects of Altitude Associated Central Apnea on the Diagnosis and Treatment of Obstructive Sleep Apnea: Comparative Data from Three Different Altitude Locations in the Mountain West

Overview
Specialties Neurology
Psychiatry
Date 2011 Dec 16
PMID 22171199
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: This study documents both the incidence and effects of central apnea on diagnosis and treatment of OSA at different altitudes in the Mountain West and substantiates the clinical impression that individuals living at altitude with moderate to severe OSA are significantly more difficult to treat with PAP.

Methods: Split-night polysomnography was compared between sites for patients with a diagnostic AHI > 15 living at 1421 meters (Site 1; N = 150), at 1808 m (Site 2; N = 150) and at 2165 m (Site 3; N = 142). The quality of PAP titration obtained was rated, based on AASM clinical guidelines, from 1 = optimal to 4 = unacceptable. Patients developing central apneas during PAP therapy (CAI > 5.0) were titrated with an alternative O(2) > CPAP/Bilevel PAP protocol.

Results: The mean number of central apneas in the diagnostic portion of studies was significantly higher (p < 0.01) at Sites 2 (19.26) and 3 (12.36) than at Site 1 (3.11). Mean numbers of central apneas/h developing on treatment with PAP varied from 4.8/h at Site 1, to 9.79/h at Site 2, to 19.25/h at Site 3 (p < 0.001). At Site 1, 10.6% had a central apnea index (CAI) > 5.0, while 22% met this criterion at Site 2 and 38.7% at Site 3 (Site 3 vs Site 1, p = 0.01; Site 2 vs Site 1, p = 0.02). Rated titration quality varied significantly between sites. At Site 1, mean titration quality was 1.437 (SD 0.821); for Site 2, 1.569 (SD 0.96), and for Site 3, 1.772 (SD 1.025). Titration quality at Site 3 was significantly worse than at Site 1 (t = 3.22, p < 0.01) and at Site 2 (t = 2.55, p < 0.02). Repeat titration requirement differed significantly (p = 0.025). Analysis of covariance comparing titration across 3 altitude levels, controlling for age, was significant for the effect of altitude (p = 0.017). Utilizing the alternative O(2) > C-PAP/Bi-PAP protocol in patients with CAI > 5.0 developing on PAP treatment, an overall optimal or good titration (AASM criteria) was attained in 75/79 (95%) of titrated patients.

Conclusions: This study demonstrates that central apnea becomes significantly more common at increasing altitude in both diagnostic and treatment portions of split-night polysomnography in patients with significant OSA. An apparent exponential increase in the percentage of OSA patients with a CAI > 5.0 occurs with increasing altitude. Altitude associated central apnea has a significant negative effect on the quality of OSA treatment obtained during PAP titration for patients living at the altitudes addressed in this study.

Citing Articles

Management of central sleep apnoea: a review of non-hypercapnic causes.

Zheng Y, Tai J, Yee B Breathe (Sheff). 2024; 20(3):230235.

PMID: 39534487 PMC: 11555585. DOI: 10.1183/20734735.0235-2023.


Altitude and Breathing during Sleep in Healthy Persons and Sleep Disordered Patients: A Systematic Review.

Rojas-Cordova S, Torres-Fraga M, Rodriguez-Reyes Y, Guerrero-Zuniga S, Vazquez-Garcia J, Carrillo-Alduenda J Sleep Sci. 2023; 16(1):117-126.

PMID: 37151770 PMC: 10157825. DOI: 10.1055/s-0043-1767745.


Sensitivity and specificity of four screening sleep-disordered breathing tests in patients with and without cardiovascular disease.

Amado-Garzon S, Ruiz A, Rondon-Sepulveda M, Hidalgo-Martinez P Sleep Sci. 2022; 14(4):311-318.

PMID: 35087627 PMC: 8776260. DOI: 10.5935/1984-0063.20200104.


Optimal NIV Medicare Access Promotion: Patients With Central Sleep Apnea: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the....

Morgenthaler T, Malhotra A, Berry R, Johnson K, Raphaelson M Chest. 2021; 160(5):e419-e425.

PMID: 34339687 PMC: 8628167. DOI: 10.1016/j.chest.2021.07.039.


Is idiopathic central sleep apnea a separate entity?.

Diaz S, Brown L J Clin Sleep Med. 2020; 16(12):1999-2001.

PMID: 33063658 PMC: 7848928. DOI: 10.5664/jcsm.8926.


References
1.
Zielinski J, Koziej M, Mankowski M, Sarybaev A, Tursalieva J, Sabirov I . The quality of sleep and periodic breathing in healthy subjects at an altitude of 3,200 m. High Alt Med Biol. 2001; 1(4):331-6. DOI: 10.1089/15270290050502408. View

2.
Gilmartin G, Daly R, Thomas R . Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med. 2005; 11(6):485-93. DOI: 10.1097/01.mcp.0000183061.98665.b0. View

3.
Hoshikawa M, Uchida S, Sugo T, Kumai Y, Hanai Y, Kawahara T . Changes in sleep quality of athletes under normobaric hypoxia equivalent to 2,000-m altitude: a polysomnographic study. J Appl Physiol (1985). 2007; 103(6):2005-11. DOI: 10.1152/japplphysiol.00315.2007. View

4.
Morgenthaler T, Kagramanov V, Hanak V, Decker P . Complex sleep apnea syndrome: is it a unique clinical syndrome?. Sleep. 2006; 29(9):1203-9. DOI: 10.1093/sleep/29.9.1203. View

5.
Skatrud J, Dempsey J, Badr S, Begle R . Effect of airway impedance on CO2 retention and respiratory muscle activity during NREM sleep. J Appl Physiol (1985). 1988; 65(4):1676-85. DOI: 10.1152/jappl.1988.65.4.1676. View